Abstract
Metastasis to the pancreas is rare, especially for malignant melanoma. In these scarce cases, tumors normally present in the parenchyma of the pancreas. A 70-year-old woman was referred to our hospital for an asymptomatic pancreatic tumor detected by contrast-enhanced computed tomography (CE-CT). She had undergone a pneumonectomy for primary malignant melanoma (MM) of the lung approximately 3 years prior and was receiving nivolumab for recurrent intrapulmonary metastasis. CE-CT revealed a hypo-vascular lesion occluding the main pancreatic duct (MPD) which was consequently dilated. On magnetic resonance imaging, the MPD lesion had high signal intensity on T1-weighted and diffusion-weighted images. Contrast-enhanced endoscopic ultrasonography revealed that the low echoic tumor had heterogenous enhancement in the early phase. Endoscopic retrograde pancreatography (ERP) was performed for evaluation of tumor area and histological diagnosis. A contrast agent defected lesion was observed in the dilated MPD from the pancreas body to tail suggesting the tumor totally occluded the MPD. Biopsy was performed and the specimens obtained from the defect lesion were black in color. Histopathological examination of the black specimens revealed substantial growth of tumor cells with eosinophilic cytoplasm and unequal nuclei size. The tumor cells had a brownish pigmentation of melanin. From these findings, the tumor was diagnosed as pancreatic metastasis of MM. The patient underwent chemotherapy with ipilimumab and nivolumab. The final diagnosis was pancreatic metastasis of MM occurring as a tumor occluding the MPD. ERP was useful for histological diagnosis and could be useful for future cases.
Similar content being viewed by others
Abbreviations
- CE-CT:
-
Contrast-enhanced computed tomography
- MM:
-
Malignant melanoma
- MPD:
-
Main pancreatic duct
- MRI:
-
Magnetic resonance imaging
- EUS:
-
Endoscopic ultrasonography
- ERP:
-
Endoscopic retrograde pancreatography
- EUS-FNA/B:
-
Endoscopic ultrasound-guided fine-needle aspiration/biopsy
- PEP:
-
Post-endoscopic retrograde cholangiopancreatography pancreatitis
References
Larsen AK, Krag C, Geertsen P, Jakobsen LP. Isolated malignant melanoma metastasis to the pancreas. Plast Reconstr Surg Glob Open. 2013;1: e74.
McLoughlin JM, Zager JS, Sondak VK, Berk LB. Treatment options for limited or symptomatic metastatic melanoma. Cancer Control. 2008;15:239–47.
Deutsch GB, Flaherty DC, Kirchoff DD, et al. Association of surgical treatment, systemic therapy, and survival in patients with abdominal visceral melanomametastases, 1965–2014: relevance of sugical cure in the era of modern systemic therapy. JAMA Surg. 2017;152:672–8.
Atlas SW, Braffmann BH, LoBrutto R, Elder DE, Herlyn D. Human malignant melanomas with varying degrees of melanin content in nude mice: MR imaging, histopathology, and electron paramagnetic resonance. J Comput Assist Tomogr. 1990;14:547–54.
Hopkins ZH, Carlisle RP, Frost ZE, et al. Risk factors and predictors of survival among patients with amelanotic melanoma compared to melanotic melanoma in the national cancer database. J Clin Aesthet Dermatol. 2021;14:36–43.
Nakamura Y, Yamada R, Kaneko M, et al. Isolated pancreatic metastasis from malignant melanoma: a case report and literature review. Clin J Gastroenterol. 2019;12:626–36.
Yamaguchi H, Shimizu M, Ban S, et al. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2009;33:1164–72.
Hijioka S, Hifumi M, Mekky MA, et al. Total pancreatectomy for metastatic renal cell carcinoma with marked extension into the main pancreatic duct. Intern Med. 2010;49:557–62.
Pang JC, Roh MH. Metastases to the pancreas encountered on endoscopic ultrasound-guided fine-needle aspiration. Arch Pathol Lab Med. 2015;139:1248–52.
Ribeiro IB, do Monte Junior ES, Miranda Neto AA. Pancreatitis after endoscopic retrograde cholangiopancreatography: a narrative review. World J Gastroenterol. 2021;27:2495–506.
Yokode M, Matsumori T, Uza N. Pancreatic duct biopsies using a novel device delivery system for preoperative evaluation of main duct intraductal papillary mucinous neoplasm. Dig Endosc. 2022;34(4):e83–4. https://doi.org/10.1111/den.14280 (Online ahead of print).
Matsumori T, Uza N, Shiokawa M, et al. Clinical impact of a novel device delivery system in the diagnosis of bile duct lesions: A single-center experience. J Gastroenterol Hepatol. 2022. https://doi.org/10.1111/jgh.15866 (Online ahead of print).
Funding
The authors declare no funding for this article.
Author information
Authors and Affiliations
Contributions
KM, TM, KK, HT, MM, SY, and NU participated in diagnosis and drafted the manuscript. HS supervised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All authors report no conflict of interest concerning the materials or methods uses in this study or the findings specified in this paper. Authors declare no conflicts of interest for this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mizukoshi, K., Matsumori, T., Kurokawa, K. et al. Pancreatic metastasis of malignant melanoma presenting as a tumor occluding the main pancreatic duct. Clin J Gastroenterol 15, 994–998 (2022). https://doi.org/10.1007/s12328-022-01655-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-022-01655-z